drugset / Trial / NCT00749463

Evaluation of the Safety Profile, Quit and Reduction Rate After Nicorette® Gum and Patch Treatment

NCT00749463

Phase 4 Completed 300 enrolled McNeil AB
Non-randomizedParallel-groupOpen-labelTreatment

Summary

To evaluate the safety, smoking cessation and reduction rate during 3 months of active nicotine replacement therapy (NRT) and a follow-up period of 3 months in smoking hospital physicians and staff who are motivated to quit

Timeline

Start
2009-02
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 2 mg
Subject Nicotine Unknown 4 mg
Subject Nicotine Unknown 15 mg

Indications